Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection (clinicaltrials.gov) - Jun 1, 2022 - P3 | N=250 | Recruiting | Sponsor: Valenta Pharm JSC | Not yet recruiting ➔ Recruiting | Trial completion date: Dec 2022 ➔ Dec 2023 | Trial primary completion date: Dec 2022 ➔ Dec 2023
Enrollment open • Trial completion date • Trial primary completion date • Cough • Infectious Disease • Respiratory Diseases
|